Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 10 | 129471045 | intron variant | C/A;G;T | snv |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.040 | 10 | 129471045 | intron variant | C/A;G;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.120 | 10 | 129683009 | intron variant | C/A;T | snv |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.120 | 10 | 129683009 | intron variant | C/A;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2008 | 2012 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2007 | 2013 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2007 | 2013 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2007 | 2013 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | < 0.001 | 1 | 2005 | 2005 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.080 | 10 | 129676210 | intron variant | G/A | snv | 0.15 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
10 | 129627758 | intron variant | T/C | snv | 0.45 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
10 | 129642165 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
10 | 129759310 | missense variant | G/A | snv | 8.5E-04 | 2.9E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
10 | 129759310 | missense variant | G/A | snv | 8.5E-04 | 2.9E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.040 | 10 | 129466848 | upstream gene variant | G/A | snv | 4.8E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 10 | 129466848 | upstream gene variant | G/A | snv | 4.8E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.280 | 10 | 129766906 | missense variant | A/G | snv | 9.4E-02 | 8.7E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 |